Clinical Trials Directory

Trials / Completed

CompletedNCT02195648

Sub-occipital Muscle Inhibition in Tension Type Headache

Treatment Efficacy of Tension Type Headache After Application of Sub-occipital Muscle Inhibition Technique Associated With Interferential Electrotherapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Universidad Católica San Antonio de Murcia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to determine the effects caused in neck movement, neck pain, headache in patients with tension type headache and cervicogenic headache after application of sub-occipital muscle inhibition technique associated with interferential electrotherapy.

Detailed description

This study is based on the combined application of sub-occipital muscle inhibition technique associated with interferential electrotherapy improves symptoms in patients with tension type headache and cervicogenic headache. The purposes of this study are: * Evaluate the effectiveness of treatment based on the combined application of sub-occipital muscle inhibition technique associated with interferential electrotherapy in patients with tension type headache. * Evaluate the effects of treatment caused in upper cervical movement. * Evaluate the effects of treatment caused in neck pain. * Evaluate the effects of treatment caused in headache.

Conditions

Interventions

TypeNameDescription
OTHERSuboccipital inhibitionExperimental: Suboccipital inhibition The intervention group will receive a session of 20 minutes (5 minutes for the patient's reception, 10 for treatment and the following 5 minutes for rest and hemodynamic stabilization), twice a week for 4 weeks. The intervention will consist of suboccipital muscle inhibition and interferential current on the occipital muscles.

Timeline

Start date
2015-02-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2014-07-21
Last updated
2018-04-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02195648. Inclusion in this directory is not an endorsement.